Search Results - "Mahadevan, Sankar"

Fault detection and diagnosis in process data using one-class support vector machines by Mahadevan, Sankar, Shah, Sirish L.

“…In this paper, a new approach for fault detection and diagnosis based on One-Class Support Vector Machines (1-class SVM) has been proposed. The approach is…”
Get full text

Analysis of Metabolomic Data Using Support Vector Machines by Mahadevan, Sankar, Shah, Sirish L, Marrie, Thomas J, Slupsky, Carolyn M

“…Metabolomics is an emerging field providing insight into physiological processes. It is an effective tool to investigate disease diagnosis or conduct…”
Get full text

Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program by Vidhubala, E., Niraimathi, K., Shewade, Hemant Deepak, Mahadevan, Sankar

“…In India, cervical cancer screening is conducted at various levels; however, after screening, the adherence to the cancer care continuum is barely understood…”
Get full text

Call for Systematic Population-Based Cervical Cancer Screening: Findings from Community-Based Screening Camps in Tamil Nadu, India by Vidhubala, Elangovan, Shewade, Hemant Deepak, Niraimathi, Anandan K, Ramkumar, Sethupathy, Ramaswamy, Gomathi, Nagalekshmi, G, Sankar Mahadevan, B

“…In India, systematic cervical cancer screening under the national programme is yet to cover the entire population and therefore opportunistic or camp based…”
Get full text

Loss to follow-up after initial screening for cervical cancer: A qualitative exploration of barriers in Southern India by E Vidhubala, Hemant Deepak Shewade, K Niraimathi, Amol R Dongre, Ramaswamy Gomathi, S Ramkumar, Mahadevan B Sankar

“…Background: In India, opportunistic screening is routinely conducted for cervical cancer, but systematic, community-based screening is relatively new. Hence,…”
Get full text

The Use of Fedratinib for Myelofibrosis As a Potential Bridge to Hematopoietic Stem Cell Transplantation after Ruxolitinib Failure: Real-World Assessment of Treatment Characteristics and Spleen, Symptom, and Hematologic Response by Mascarenhas, John, Harrison, Claire, Schuler, Tammy, Liassou, Djibril, Garretson, Marné, Mahadevan, Sankar, McBride, Ali, Tang, Derek, DeGutis, Irene S., Abraham, Pranav, Gerds, Aaron T.

Get full text

Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical Outcomes by Mascarenhas, John, Harrison, Claire, Schuler, Tammy A, Liassou, Djibril, Garretson, Marné, Miller, Taavy A, Mahadevan, Sankar, McBride, Ali, Tang, Derek, DeGutis, Irene S, Abraham, Pranav, Kish, Jonathan, Feinberg, Bruce A, Gerds, Aaron T

“…There is a lack of established clinical outcomes for patients with myelofibrosis (MF) receiving fedratinib following ruxolitinib failure. This study examined…”
Get full text